Crossmark

SLC1A3 is a novel prognostic biomarker associated with immunity and EMT in hepatocellular carcinoma

Published Online: 2024-11-19

Authors

Zhi, Renhou

Fan, Fan
License Information

Text and Data Mining valid from 2024-11-19

Version of Record valid from 2024-11-19
More Information

Article History

Received: 8 September 2024

Accepted: 8 November 2024

First Online: 19 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current